A Study of Olanzapine in Patients With Schizophrenia
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study is to confirm if the efficacy of intramuscular injection
(IM) olanzapine 10 milligrams (mg) in patients with an exacerbation of schizophrenia with
acute psychotic agitation is greater than intramuscular placebo by comparing changes from
baseline to 2 hours after the first IM injection of agitation.